New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes

OBJECTIVE: The antidiabetic properties of metformin are mediated through its ability to activate the AMP-activated protein kinase (AMPK). Activation of AMPK can suppress tumor formation and inhibit cell growth in addition to lowering blood glucose levels. We tested the hypothesis that metformin redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Libby, Gillian, Donnelly, Louise A., Donnan, Peter T., Alessi, Dario R., Morris, Andrew D., Evans, Josie M.M.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732153/
https://www.ncbi.nlm.nih.gov/pubmed/19564453
http://dx.doi.org/10.2337/dc08-2175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732153/
https://www.ncbi.nlm.nih.gov/pubmed/19564453
http://dx.doi.org/10.2337/dc08-2175

Ejemplares similares